Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combining insulin and oral agents.

J Buse1

  • 1University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27713, USA. john_buse@med.unc.edu

The American Journal of Medicine
|April 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taxonomic and Trophic Groups Mediate Latitudinal Variation in Saproxylic Beetle Species Richness and Body Size Across Western Palaearctic Oak Forests.

Ecology and evolution·2025
Same author

Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay.

Clinical biochemistry·2017
Same author

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.

Diabetes, obesity & metabolism·2012
Same author

Cardiovascular risk factors in multi-ethnic middle school students: the HEALTHY primary prevention trial.

Pediatric obesity·2012
Same author

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Diabetologia·2012

Combination therapy with insulin and oral antidiabetic agents can achieve excellent glycemic control in type 2 diabetes patients. This approach may reduce insulin dosage and mitigate weight gain, improving treatment outcomes.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) is a progressive condition requiring sustained glycemic control to prevent vascular complications.
  • While single or combined oral agents and insulin can achieve glycemic targets, secondary failure rates are high, particularly in long-standing T2DM.
  • Combination therapy with insulin and oral antidiabetic agents offers a viable strategy for improving glycemic control.

Purpose of the Study:

  • To review the evidence supporting combination therapy for type 2 diabetes.
  • To discuss the benefits and challenges of using insulin with oral antidiabetic agents.
  • To highlight the need for further research into optimal combination regimens.

Main Methods:

  • Review of randomized, prospective clinical trials and existing literature.

Related Experiment Videos

  • Analysis of data on combinations of insulin with sulfonylureas, thiazolidinediones, metformin, and acarbose.
  • Evaluation of glycemic control, insulin dosage, and weight management outcomes.

    • Main Results:

    • Combination therapy with insulin and oral agents can safely achieve excellent glycemic control in most T2DM patients.
    • This approach can reduce insulin dosage requirements and, in some cases, mitigate insulin-associated weight gain.
    • Convenient insulin delivery systems may increase patient and clinician acceptance of combination therapy.

    Conclusions:

    • Combination therapy, particularly with insulin and oral agents, is effective for managing type 2 diabetes.
    • While several combinations have demonstrated benefits, optimal regimens, insulin formulations, and dosages require further investigation.
    • Continued research is essential to guide the selection of the most effective and personalized combination therapies for T2DM.